Immediate Impact
71 standout
Citing Papers
Bladder cancer
2023 Standout
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice
2023 Standout
Works of Michael Porter being referenced
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
2013
1160 SMOKING AND RISK OF UROTHELIAL CELL CARCINOMA OF THE BLADDER: RESULTS FROM A CONTEMPORARY, PROSPECTIVE COHORT STUDY
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Porter | 118 | 153 | 75 | 92 | 23 | 388 | |
| Marco Amato | 227 | 121 | 43 | 135 | 32 | 429 | |
| Laura Peters | 59 | 200 | 51 | 67 | 15 | 377 | |
| Moben Mirza | 184 | 79 | 40 | 104 | 40 | 417 | |
| Michael R. Ehmann | 97 | 79 | 21 | 69 | 33 | 448 | |
| Tomas Sjöberg Bexelius | 140 | 96 | 32 | 94 | 29 | 411 | |
| Simone Cilio | 117 | 80 | 72 | 51 | 46 | 435 | |
| Heather Deans | 45 | 76 | 24 | 117 | 19 | 405 | |
| Ceri Beaton | 134 | 144 | 43 | 207 | 20 | 392 | |
| Jason A. Freed | 31 | 97 | 75 | 55 | 38 | 395 | |
| L Lovén | 137 | 68 | 65 | 131 | 27 | 434 |
All Works
Loading papers...